Annual ROE:
-231.63%-72.42%(-45.49%)Summary
- As of today, AXSM annual return on equity is -231.63%, with the most recent change of -72.42% (-45.49%) on December 31, 2024.
- During the last 3 years, AXSM annual ROE has fallen by -30.12% (-14.95%).
- AXSM annual ROE is now -223.62% below its all-time high of 187.37%, reached on December 31, 2014.
Performance
AXSM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-325.69%-16.50%(-5.34%)Summary
- As of today, AXSM quarterly return on equity is -325.69%, with the most recent change of -16.50% (-5.34%) on June 30, 2025.
- Over the past year, AXSM quarterly ROE has dropped by -169.25% (-108.19%).
- AXSM quarterly ROE is now -168.39% below its all-time high of 476.20%, reached on September 30, 2015.
Performance
AXSM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AXSM ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -45.5% | -108.2% |
| 3Y3 Years | -14.9% | +30.6% |
| 5Y5 Years | -204.5% | -257.6% |
AXSM ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -45.5% | +22.5% | -199.2% | at low |
| 5Y | 5-Year | -229.2% | +22.5% | -367.3% | +30.6% |
| All-Time | All-Time | -223.6% | +34.0% | -168.4% | +38.5% |
AXSM ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -325.69%(-5.3%) |
| Mar 2025 | - | -309.19%(-26.6%) |
| Dec 2024 | -231.63%(-45.5%) | -244.32%(-25.8%) |
| Sep 2024 | - | -194.28%(-24.2%) |
| Jun 2024 | - | -156.44%(-5.1%) |
| Mar 2024 | - | -148.91%(-19.6%) |
| Dec 2023 | -159.21%(+46.7%) | -124.52%(-14.4%) |
| Sep 2023 | - | -108.86%(+20.6%) |
| Jun 2023 | - | -137.09%(+29.4%) |
| Mar 2023 | - | -194.21%(+35.1%) |
| Dec 2022 | -298.97%(-48.4%) | -299.47%(+8.0%) |
| Sep 2022 | - | -325.46%(+30.7%) |
| Jun 2022 | - | -469.46%(-60.6%) |
| Mar 2022 | - | -292.34%(-52.4%) |
| Dec 2021 | -201.51%(-186.4%) | -191.84%(-40.4%) |
| Sep 2021 | - | -136.66%(-37.3%) |
| Jun 2021 | - | -99.50%(-30.9%) |
| Mar 2021 | - | -76.00%(-9.0%) |
| Dec 2020 | -70.36%(+7.5%) | -69.70%(+10.7%) |
| Sep 2020 | - | -78.06%(+14.3%) |
| Jun 2020 | - | -91.07%(+22.6%) |
| Mar 2020 | - | -117.63%(+21.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -76.08%(+78.3%) | -149.79%(+71.7%) |
| Sep 2019 | - | -529.66%(-26.1%) |
| Jun 2019 | - | -419.91%(+11.8%) |
| Mar 2019 | - | -476.08%(-16.8%) |
| Dec 2018 | -350.78%(-132.0%) | -407.52%(-52.5%) |
| Sep 2018 | - | -267.18%(-50.5%) |
| Jun 2018 | - | -177.53%(-35.4%) |
| Mar 2018 | - | -131.16%(+2.9%) |
| Dec 2017 | -151.19%(-89.0%) | -135.04%(-11.1%) |
| Sep 2017 | - | -121.56%(-12.3%) |
| Jun 2017 | - | -108.28%(-14.6%) |
| Mar 2017 | - | -94.51%(-19.8%) |
| Dec 2016 | -79.99%(-41.6%) | -78.92%(-37.8%) |
| Sep 2016 | - | -57.27%(+4.5%) |
| Jun 2016 | - | -59.98%(+11.4%) |
| Mar 2016 | - | -67.73%(+7.8%) |
| Dec 2015 | -56.48%(-130.1%) | -73.44%(-115.4%) |
| Sep 2015 | - | 476.20%(+312.5%) |
| Jun 2015 | - | 115.45%(-4.8%) |
| Mar 2015 | - | 121.23%(+122.8%) |
| Dec 2014 | 187.37%(+74.9%) | 54.41% |
| Dec 2013 | 107.11% | - |
FAQ
- What is Axsome Therapeutics, Inc. annual return on equity?
- What is the all-time high annual ROE for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. annual ROE year-on-year change?
- What is Axsome Therapeutics, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. quarterly ROE year-on-year change?
What is Axsome Therapeutics, Inc. annual return on equity?
The current annual ROE of AXSM is -231.63%
What is the all-time high annual ROE for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high annual return on equity is 187.37%
What is Axsome Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, AXSM annual return on equity has changed by -72.42% (-45.49%)
What is Axsome Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of AXSM is -325.69%
What is the all-time high quarterly ROE for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high quarterly return on equity is 476.20%
What is Axsome Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, AXSM quarterly return on equity has changed by -169.25% (-108.19%)